EHI
Eagle Health Investments Portfolio holdings
AUM
$405M
This Quarter Return
+11.9%
1 Year Return
+14.19%
3 Year Return
+134.25%
5 Year Return
–
10 Year Return
–
AUM
$156M
AUM Growth
–
Cap. Flow
+$156M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
68.32%
Holding
24
New
24
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
IQVIA
IQV
|
$13M |
| 2 |
Humana
HUM
|
$12.8M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$12.3M |
| 4 |
Thermo Fisher Scientific
TMO
|
$11.6M |
| 5 |
AstraZeneca
AZN
|
$11.5M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 99.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
IQVIA
IQV
$32.4B
| $13M | 8.29% | +72,377 | New | +$13M |
|
|
2
Humana
HUM
$36.5B
| $12.8M | 8.18% | +31,162 | New | +$12.8M |
|
|
3
Vertex Pharmaceuticals
VRTX
$100B
| $12.3M | 7.86% | +52,000 | New | +$12.3M |
|
|
4
Thermo Fisher Scientific
TMO
$186B
| $11.6M | 7.4% | +24,851 | New | +$11.6M |
|
|
5
AstraZeneca
AZN
$248B
| $11.5M | 7.36% | +230,100 | New | +$11.5M |
|
6
Alnylam Pharmaceuticals
ALNY
$58.5B
| $11.2M | 7.13% | +85,793 | New | +$11.2M |
|
7
United Therapeutics
UTHR
$13.8B
| $10.6M | 6.8% | +70,000 | New | +$10.6M |
|
|
AXNX
8
DELISTED
Axonics, Inc. Common Stock
AXNX
| $9.13M | 5.84% | +182,840 | New | +$9.13M |
|
9
Natera
NTRA
$23.1B
| $7.82M | 5% | +78,600 | New | +$7.82M |
|
|
BPMC
10
DELISTED
Blueprint Medicines
BPMC
| $6.96M | 4.45% | +62,060 | New | +$6.96M |
|
|
ALXN
11
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $6.71M | 4.29% | +42,929 | New | +$6.71M |
|
12
Illumina
ILMN
$15.8B
| $5.81M | 3.72% | +15,700 | New | +$5.81M |
|
13
argenx
ARGX
$43.6B
| $5.76M | 3.68% | +19,587 | New | +$5.76M |
|
14
DexCom
DXCM
$29.5B
| $5.1M | 3.26% | +13,800 | New | +$5.1M |
|
15
Adaptive Biotechnologies
ADPT
$2.01B
| $4.94M | 3.16% | +83,535 | New | +$4.94M |
|
16
Guardant Health
GH
$8.41B
| $4.18M | 2.68% | +32,460 | New | +$4.18M |
|
17
Outset Medical
OM
$247M
| $4.09M | 2.62% | +72,000 | New | +$4.09M |
|
18
Agios Pharmaceuticals
AGIO
$2.19B
| $3.02M | 1.93% | +69,700 | New | +$3.02M |
|
|
CANO
19
DELISTED
Cano Health, Inc.
CANO
| $2.53M | 1.62% | +188,300 | New | +$2.53M |
|
20
Butterfly Network
BFLY
$405M
| $2.26M | 1.44% | +114,100 | New | +$2.26M |
|
21
4D Molecular Therapeutics
FDMT
$288M
| $2.07M | 1.33% | +50,000 | New | +$2.07M |
|
|
DRNA
22
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.52M | 0.97% | +69,000 | New | +$1.52M |
|
23
Seer Inc
SEER
$115M
| $1.12M | 0.72% | +20,000 | New | +$1.12M |
|
|
CMAX
24
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $421K | 0.27% | +27,008 | New | +$421K |
|